2014-2020 한국과학기술원 생명과학과 공학박사
2006-2014 충남대학교 수의학과 수의학사

2020-2022 Imperial College London - Research Associate

유전자치료제 나노입자 연구
나노의약품 품질평가 항목 표준화 연구
나노입자 전달체 연구

Y. K. Kang, H. J. Chung, “Nonviral genome editing CRISPR nanocomplex and fabrication method thereof”
(Registered, Korea, Australia 2021): Korea - Application No. 10-2017-0075053 /PCT - Application No. PCT/KR2017/013623
Y. K. Kang, S. H. Im, H. J. Chung, “Lipid conjugated genome editing protein-based CRISPR complex and fabrication method
thereof” (Registered, 2022): Korea - Application No. 10-2019-0129452
S. Yang, J. Y. Chung, J. Lee, K. H. Lee, Y. K. Kang, H. J. Chung, An Antibody-CRISPR/Cas Conjugate Platform for
Target-Specific Delivery and Gene Editing in Cancer. Advanced science, e2308763 (2024).
A.C. Moore, M.G. Hennessy, L.P. Nogueira, S.J. Franks, M. Taffetani, H. Seong, Y.K. Kang , W.S. Tan, G. Miklosic, R. El
Laham, K. Zhou, L. Zharova, J.R. King, B. Wagner, H.J. Haugen, A. Münch, M.M. Stevens, "Fiber reinforced hydrated
networks recapitulate the poroelastic mechanics of articular cartilage" Acta Biomaterialia, 167, 69-82 (2023).
J. Lee, Y. K. Kang, E. Oh, J. Jeong, S. H. Im, D. K. Kim, H. Lee, S. Kim, K. Jung, H. J. Chung,“Nano-assembly of a
Chemically Tailored Cas9 Ribonucleoprotein for In Vivo Gene Editing and Cancer Immunotherapy.” Chemistry of Materials,
34, 2, 547–561 (2021).
Y. K. Kang, J. H. Lee, S. H. Im, J. H. Lee, J. Jeong, D. K. Kim, S.Y. Yang, K. Jung, S. Kim, H. J. Chung, “Cas9 Conjugate
Complex Delivering Donor DNA for Efficient Gene Editing by Homology-Directed Repair.” Journal of Industrial and
Engineering Chemistry, 102, 241-250 (2021).

● Particle size & zeta potential analyser

● qPCR /Thermocycler

● Fluorescence/ Luminescence plate reader

● Plasma Surface Treatment System

● Biosafety cabinets (BSCs)

● Microbiological Incubators

비바이러스성 약물전달체, 나노입자,Bioconjugation, 나노의약품, 입도평가, 세포독성, 표준화, 유전자 가위, 핵산, 생체적합성, Therapeutics